The retinal pigment epithelium (RPE) faces the photoreceptor outer segments and regulates the composition of the interstitial subretinal space. ATP enhances fluid movement from the subretinal space across the RPE. RPE cells can themselves release ATP, but the mechanisms and polarity of this release are unknown. The RPE expresses the cystic fibrosis transmembrane conductance regulator (CFTR), and CFTR is associated with ATP release in other epithelial cells. However, an increasing number of reports have suggested that the exocytotic pathway contributes to release. In the present study, we examined the involvement of CFTR and the vesicular pathway in ATP release from RPE cells. Release from cultured human ARPE-19 cells and across the apical membrane of fresh bovine RPE cells in an eyecup was studied. A cAMP cocktail to activate CFTR triggered ATP release from fresh and cultured RPE cells. Release from both RPE preparations was largely prevented by the broad-acting blocker glibenclamide and the specific thiazolidinone CFTR inhibitor CFTR-172. The block by CFTR-172 was enhanced by preincubation and prevented ATP release with 3.5 M IC50. The rise in intracellular Ca 2ϩ accompanying hypotonic challenge was prevented by CFTR-172. The vesicular transport inhibitor brefeldin A prevented ATP release after stimulation with both hypotonic and cAMP conditions, suggesting vesicular insertion was also involved. These results show an intimate involvement of CFTR in ATP release from RPE cells which can autostimulate receptors on the apical membrane to modify Ca 2ϩ signaling. The requirement for both CFTR and vesicular transport pathways suggests vesicular insertion of CFTR may underlie the release of ATP. cystic fibrosis transmembrane conductance regulator; recycling endosomes; brefeldin A; autostimulation; retinal detachment THE RETINAL PIGMENT EPITHELIUM (RPE) is a monolayer of cells lying between the retinal photoreceptors and the choroidal blood supply. The RPE functions in a glial cell-like capacity to maintain the health and signaling ability of the outer retina. The RPE supplies the outer retina with general nutrients and components critical for the visual cycle (10). The distal tips of the photoreceptor outer segments are regularly phagocytozed and metabolized by the RPE to maximize photoreceptor responsiveness (66). The RPE also regulates the ionic composition of the extracellular subretinal space surrounding the outer segments and controls the absorption of fluid from the retina to the choroid (13, 22, 32, 34, 35) .
THE RETINAL PIGMENT EPITHELIUM (RPE) is a monolayer of cells lying between the retinal photoreceptors and the choroidal blood supply. The RPE functions in a glial cell-like capacity to maintain the health and signaling ability of the outer retina. The RPE supplies the outer retina with general nutrients and components critical for the visual cycle (10) . The distal tips of the photoreceptor outer segments are regularly phagocytozed and metabolized by the RPE to maximize photoreceptor responsiveness (66) . The RPE also regulates the ionic composition of the extracellular subretinal space surrounding the outer segments and controls the absorption of fluid from the retina to the choroid (13, 22, 32, 34, 35) .
This complex interaction between the RPE and the photoreceptors is dependent on close communication between the two cell types. Various neurochemicals have been implicated in this communication, including dopamine (15, 59) , serotonin (39) , and epinephrine (13, 24, 42) . The purines ATP and adenosine also contribute to RPE-retina interaction. Stimulation of the RPE by adenosine can modify the rate of outer segment phagocytosis (17) , while stimulation of apical P2Y 2 receptors by ATP can trigger elevation of Ca 2ϩ (40, 55) . This elevation likely opens a basolateral Cl Ϫ conductance and increases the flux of ions and fluid across the RPE (40) . Triggering this fluid absorption by stimulating apical P2Y 2 receptors with agonist INS37217 can reduce the size of fluid blebs in the subretinal space (29, 31) , emphasizing the potential of purinergic signaling in the treatment of retinal detachment.
The endogenous source of ATP capable of stimulating these P2 receptors is likely the RPE cells themselves. The existence of a physiological release of ATP from epithelial cells in many different cell types is now widely accepted (6, 48, 50) , and RPE cells have been shown to release ATP in response to stimulation (14, 36) . However, the mechanisms involved in this release remain to be determined. Previous work has shown that while the Ca 2ϩ ionophore ionomycin is not sufficient to trigger release, the general Cl Ϫ channel blocker 5-nitro-2-(3-phenylpropylamino)-benzoate inhibits it, suggesting anion channel involvement (36) . RPE cells have been shown to express the anion channels ClC-2, ClC-3, ClC-5, the pCLCA1 Cl Ϫ channel regulator, and the cystic fibrosis transmembrane conductance regulator (CFTR; Refs. 4, 26, 63, 64) . Of these, ATP release has been associated most consistently with CFTR (7, 41, 52, 60) . However, recent evidence suggests that the exocytotic pathway may also be important, because substances that interfere with vesicular transport, such as botulinum toxin, tetanus neurotoxin, and brefeldin A (BFA) can prevent stimulated ATP release (5, 30, 58) . Consequently, we investigated the involvement of CFTR in ATP release from RPE cells and examined whether vesicular transport contributed to this release. Preliminary results were presented previously in abstract form (43, 44) .
MATERIAL AND METHODS
Cell culture. ARPE-19 cells (12) were obtained from the American Type Culture Collection (Manassas, VA) and grown in 25-cm 2 Falcon primary culture flasks (Becton Dickinson, Franklin Lakes, NJ) in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium with 3 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 2.5 mg/ml Fungizone, and/or 50 g/ml gentamicin (all obtained from Invitrogen, Carlsbad, CA) in the presence of 10% fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT). Cells were incubated at 37°C in 5% CO 2 and subcultured weekly with 0.05% trypsin and 0.02% EDTA.
Solutions. The isotonic solution used as a basis for all solutions was composed of (in mM) 105 NaCl, 5 KCl, 6 HEPES acid, 4 Na-HEPES, 5 NaHCO 3, 60 mannitol, 5 glucose, 0.5 MgCl2, and 1.3 CaCl2, pH 7.4. Hypotonic solution was obtained by adding the required amount of deionized distilled water, with "%hypotonicity" defined as the percentage of water added. Glibenclamide, forskolin, 3-isobutyl-1-methylxanthine (IBMX), 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA), and CFTR-172 were mixed as stock solutions in dimethyl sulfoxide. The CFTR-172 was a kind gift from A. S. Verkman (Departments of Medicine and Physiology, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA). The cAMP-stimulating mixture contained (in M) 10 forskolin, 100 IBMX and 500 8-4-chlorophenylthio(cpt)-cAMP. Brefeldin A was dissolved in ethanol. All chemicals were from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
ATP measurements from cultured cells. ATP release was detected through the chemiluminescent luciferin-luciferase reaction, and the light emitted was recorded using a microplate luminometer (Luminoskan Ascent; Labsystems, Franklin, MA). ARPE-19 cells were grown to confluence in 96-well white assay plates with clear bottoms for 4 -7 days (Corning, Corning, NY). To minimize the ATP release that accompanies solution change (18) , growth medium was removed from the cells 1 h before the experiment and replaced with 100 l of isotonic solution. After 1 h, 50 l of the isotonic solution was replaced by 50 l of a solution containing twice the drug concentration or the amount of distilled water required to obtain the final concentration or hypotonicity. To produce a 60% hypotonic solution, 60 l were removed. The plate was placed in the microplate luminometer 60 -90 s after addition of the drugs, and 10 l of the luciferase working solution were injected in each well through the internal injector system. Measurements were taken every 30 s for each well for 30 min with an integration time of 100 ms/measurement. The luciferase solution was prepared in a stock solution from one vial of the ATP assay kit diluted in 450 l of isotonic solution and 50 l of distilled water. A working solution was made by diluting 40 l of the stock solution in 1 ml of isotonic solution. The ATP released was calculated at the different time points indicated in the RESULTS with the use of a standard curve to transform the arbitrary units obtained through the luciferase reaction to an ATP concentration.
All the substances were tested for the effect on the luciferinluciferase assay as shown in Fig. 1 . Only hypotonic solutions and genistein were found to interfere with the assay itself. All of the data obtained using hypotonic solutions were corrected for this enhancement of the chemiluminescence reaction. A standard curve covering three orders of magnitude showed the relationship between luminescence and ATP concentration to be linear over the range of interest. The results from hypotonic experiments were thus scaled down by the factor shown to enhance the response to 10 nM ATP.
ATP measurements from bovine eyes. Bovine eyes were obtained from the abattoir and transported on ice to the laboratory. The eye was bisected at the ora serrata, and the retina was removed and detached from the optic nerve to expose the RPE cell layer. The eyecup was washed in isotonic solution, and then 0.5-1 ml of the control solution described above was placed in the eyecup. Next, after 10 min at room temperature, a 0.4-to 0.8-ml sample was removed. Deliberate disruption of the monolayer led to a clearly discernible discoloration of the tissue; the absence of this discoloration was assumed to indicate the presence of an intact monolayer. To determine the ATP content of each eyecup, 100 l of each sample were placed into a well of a 96-well plate, put in the microplate luminometer, and 10 l of the luciferase working solution described above were injected into each well. The initial three readings were taken to represent the ATP level.
Measurement of intracellular Ca 2ϩ . ARPE-19 cells were plated onto coverslips and grown as described above until confluent. After washing, cells were loaded with 10 M fura-2 and 0.2% pluronic acid at 37°C for 30 min. The dye was washed off, and the coverslips were mounted on a Nikon inverted microscope (Nikon Instruments, Melville, NY) and visualized with a ϫ20 objective. The field of ϳ20 cells was alternatively excited at 340 and 380 nm with a monochromator (Photon Technologies International, Lawrenceville, NJ), and the fluorescence emitted at 510 nm was detected with a photometer (Photon Technologies International). The ratio of light detected after excitation at 380 and 340 nm was converted into Ca 2ϩ concentration using a calibration performed after each measurement as previously described (36) .
Data analysis. Baseline levels of ATP varied considerably by experimental day for both fresh and cultured experiments. Efforts to remove this variability, such as limiting cell age and changing the solution 1 h before the measurements, were only partially effective, and the raw concentrations throughout the text reflect this variation. To allow comparison of experiments, values were normalized to the mean control value of each day. All data are expressed as means Ϯ SE, and the unpaired Student's t-test was used for statistical analysis, with P Ͻ 0.05 defined as significantly different. The IC50 of CFTR-172 and the EC50 of hypotonicity were determined by fitting the data curve with first-order exponential curves using SigmaPlot graphing software (SPSS, Chicago, IL).
RESULTS

Fresh vs. cultured cells.
While the cultured human ARPE-19 cells have many advantages, it was important to determine the characteristics of ATP release by fresh RPE cells and the polarity of any such release. In the RPE eyecup preparation, the apical membrane faces the cup interior, and both drug access and ATP release likely occur across the apical membrane. Initial experiments thus compared the ATP release characteristics from cultured ARPE-19 cells and the fresh bovine RPE eyecup stimulated with hypotonic solution.
ATP release from ARPE-19 cells reached a peak 10 min after the addition of a 50% hypotonic solution, after which levels slowly declined for the remainder of the 30-min measurement period ( Fig. 2A) . Peak levels rose more than eightfold in this series of experiments, from 1.7 Ϯ 0.5 nM to 14.1 Ϯ 1.6 nM (n ϭ 8 for both). The amount of ATP present in the well rose with the degree of hypotonicity Ͼ30% and reached a peak at 50% hypotonicity. Increasing hypotonicity to 60% did not produce any additional increase, giving an EC 50 of ϳ42% (Fig. 2B) .
The release from fresh bovine cells after hypotonic challenge was similar to that of the ARPE-19 cells. Because the peak from ARPE-19 cells occurred at 10 min, samples were taken from the intact bovine RPE eyecup at 10 min. Levels showed that the release across the apical membrane of fresh cells was increased significantly when challenged with 30% hypotonicity. Presentation with a 50% hypotonic solution raised ATP levels from 7.8 Ϯ 0.6 nM (n ϭ 6) to 22.2 Ϯ 2.8 nM (n ϭ 5). The ATP release pattern from fresh and cultured cells is shown in Fig. 2C . Later experiments used the minimum level of hypotonicity that reproducibly induced a significant release in each system: 30% for the fresh bovine RPE cells and 50% for the ARPE-19 cultured cells.
Release triggered by cAMP. To determine whether CFTR was involved in ATP release from RPE cells, the effect of intracellular cAMP was examined because activation by the cAMP-dependent protein kinase A is typically necessary for the opening of the CFTR conductance pathway (2). Intracellular cAMP was increased with a cAMP cocktail containing cell-permeant cpt-cAMP, forskolin, and IBMX. The cocktail triggered an immediate increase in ATP levels bathing ARPE-19 cells (Fig. 3A) . While recording from the assay plate generally began within 60 -90 s after addition of stimuli, continuous monitoring during cocktail addition confirmed that ATP levels reached their peak within 30 s. Peak levels of ATP rose fourfold when cells were exposed to the cocktail (Fig. 3B) . Although both forskolin and cpt-cAMP increased bath levels of ATP, levels were highest with the complete cocktail. Addition of the cocktail at the peak of the hypotonic response did not lead to a further increase. In fresh bovine RPE cells, the cAMP-stimulating cocktail increased ATP levels 2.5-fold, from 10.1 Ϯ 2.1 nM ATP (n ϭ 6) to 24.3 Ϯ 9.3 nM ATP (n ϭ 6, Fig. 3C ). Forskolin itself led to a small but not significant increase in the fresh cells. Because the CFTR activator genistein significantly inhibited the luciferin-luciferase assay (Fig. 1) , it was not possible to reliably quantify its enhancement of ATP release.
CFTR blockers. Pharmacological tools were used to further elucidate the contribution of CFTR to ATP release from RPE cells. Because glibenclamide can block the Cl Ϫ current associated with CFTR (65), its effects on ATP release were determined. When glibenclamide (100 M) and hypotonic solutions were added together to the ARPE-19 cells, a reduction in ATP was seen throughout the experiment (Fig. 4A) . In this series of experiments, hypotonicity increased peak ATP levels 8.9-fold, from 3.3 Ϯ 1.1 nM (n ϭ 6) to 29.1 Ϯ 3.8 nM (n ϭ 7). Glibenclamide blocked 71% of the peak response, with levels of 9.7 Ϯ 1.5 nM (n ϭ 6). A summary of the effects of 100 M glibenclamide from all trials is shown in Fig. 4B . The drug produced a complete block of ATP release from bovine RPE cells when used at 100 M (Fig. 4C) . Hypotonicity raised ATP 2.2-fold in the bovine RPE eyecup, from 0.26 Ϯ 0.02 nM (n ϭ 6) to 0.35 Ϯ 0.04 nM (n ϭ 7). In the presence of 100 M glibenclamide, hypotonicity raised ATP to only 0.13 Ϯ 0.02 nM (n ϭ 5; not significantly different from control). Levels were particularly low in this set of experiments, but they were consistent, as evidenced by the small variation.
Although the block by glibenclamide suggested that CFTR contributes to ATP release from the RPE, the drug is not specific for CFTR. A thiazolidinone blocker, CFTR-172, that inhibits CFTR with far greater potency and specificity than glibenclamide was recently identified by Verkman and colleagues (28, 56) . CFTR-172 was used to provide a more decisive assessment of the CFTR contribution to ATP release. The blocker CFTR-172 inhibited hypotonically triggered release from ARPE-19 cells (Fig. 5A) . When the drug was added simultaneously with the hypotonic solution, minimal block was observed, but inhibition was considerably increased by preincubating the cells with 10 M CFTR-172 for 30 min (Fig. 5B) . Preincubation with 10 M CFTR-172 decreased the ATP levels bathing ARPE-19 during hypotonic exposure by 79.3%, from 13.4 Ϯ 1.0 nM ATP (n ϭ 23) to 4.3 Ϯ 1.2 nM ATP (n ϭ 12), compared with control of 1.9 Ϯ 0.1 nM (n ϭ 46). The decrease in ATP levels was concentration dependent, with an IC 50 of 3.5 M when preincubated for 30 min. CFTR-172 completely blocked the hypotonically triggered release from fresh bovine cells (Fig 5C) . Hypotonicity (30%) raised the peak ATP concentration 1.7-fold, from 8.5 Ϯ 2.0 nM (n ϭ 12) to 14.9 Ϯ 3.2 nM (n ϭ 8). CFTR-172 reduced the level by 95%, to 8.9 Ϯ 3.4 nM (n ϭ 8).
Effect on intracellular Ca 2ϩ . , with a large, transient increase followed by a slow rise in Ca 2ϩ (Fig. 6A) . The inhibitor CFTR-172 greatly diminished both Ca 2ϩ responses. Cells exposed to 10 M CFTR-172 for 30 min before and during hypotonic challenge showed a 95% reduction in the transient peak and a 42% reduction in the delayed Ca 2ϩ peak (Fig. 6B) . In both cases, a net reduction in Ca 2ϩ concentration was observed in response to hypotonicity, possibly because of the dilution of cellular constituents. Because CFTR-172 did not affect levels in isotonic solution or calibration readings, the inhibition was specific for stimulated release of ATP. This implies that CFTR-associated release of ATP is capable of autostimulating receptors on the RPE and suggests that this . Symbols represent means Ϯ SE of a set of experiments; n ϭ 6 -7. B: summary of experiments showing that glibenclamide significantly reduced the peak ATP levels surrounding ARPE-19 cells exposed to a 50% hypotonic solution. *P Ͻ 0.001, significantly different from control. **P Ͻ 0.001, significantly different from hypotonic condition. C: in fresh bovine RPE cells, ATP release triggered by a 30% hypotonic solution was blocked completely by glibenclamide (100 M). *P ϭ 0.006, significantly different from control. **P ϭ 0.004, significantly different from hypotonic condition. Bars, means Ϯ SE.
release is responsible for both the fast and slow elevations in Ca 2ϩ after hypotonic challenge. Involvement of vesicular transport. While the above experiments with CFTR-172 clearly establish a predominant role for CFTR in the release of ATP, the effects of BFA on ATP release were examined to determine whether the vesicular release pathway was also involved in the response. ARPE-19 cells were preincubated with 10 g/ml BFA for 2 h before exposure to a 50% hypotonic solution. The BFA slowed the initial release of ATP and led to a reduced level of extracellular ATP throughout the experimental period (Fig. 7A) . In these experiments, hypotonicity increased the ATP levels 5.1-fold to 7.3 Ϯ 0.5 nM (n ϭ 36) from 1.2 Ϯ 0.1 nM (n ϭ 26; Fig. 7B ). A 2-h preincubation with BFA led to a 70% reduction in peak ATP concentration, with mean levels of 3.8 Ϯ 0.3 nM (n ϭ 19). To determine whether vesicular transport made a similar contribution to both hypotonic and cAMP-triggered release, the effect of BFA on the release after cAMP stimulation was examined. In this set of experiments, the cAMP cocktail increased the ATP levels 1.5-fold to 4.0 Ϯ 0.6 nM (n ϭ 72) from 2.6 Ϯ 0.2 nM (n ϭ 84). However, a 2-h preincubation with BFA reduced ATP release by 79%, to 2.9 Ϯ 0.2 nM (n ϭ 60; Fig. 7C ).
Several controls were performed to further explain the dramatic block of ATP release by BFA. While BFA had no effect on the luciferase assay (Fig. 1) , the inhibition was clearly dependent on exposure time, with a 10-min preincubation producing a smaller reduction in ATP release. Hypotonicity . A large and fast increase was detected soon after the reduction of the osmolarity, followed by a second slow rise from the lowest point with a maximum 10 -15 min after the stimuli presentation (solid line). The inhibitor CFTR-172 (shaded line) completely inhibited the fast peak and significantly blocked the slow rise after a 30-min preincubation at 10 M concentration. Inset shows the secondary response on an expanded scale. The lines show a representative experiment using ϳ20 confluent cells each. B: summary of the effects of the inhibitor CFTR-172 on the changes in intracellular Ca 2ϩ observed in the ARPE-19 cells by the action of the 50% hypotonic solution. Preincubation with 10 M CFTR-172 produced complete inhibition of the fast peak and a significant inhibition of the slow secondary rise. Change in Ca 2ϩ is defined as from control baseline to maximum peak for the first event and from the lowest posthypotonicity point to the second maximum for the slow rise. Bars, means Ϯ SE; n ϭ no. of recordings from ϳ20 cells each. *P Ͻ 0.001 vs. hypotonic solution alone: **P ϭ 0.031 vs. hypotonic solution alone. increased ATP levels by 4.9 Ϯ 0.11-fold after a 10-min incubation in BFA (n ϭ 10; P ϭ 0.15, not significantly different from hypotonic alone) (Fig. 7B) . Likewise, the reduction in cAMP-triggered release found after a 10-min incubation with BFA was not significant (Fig. 7C) . BFA had a similar effect on the baseline release of ATP; preincubation for 10 min reduced basal levels by 13% (from 1.5 Ϯ 0.08 nM; n ϭ 24 to 1.3 Ϯ 0.1 nM; n ϭ 12), while a 2-h preincubation led to a significant reduction of 27% (to 1.1 Ϯ 0.07 nM; n ϭ 12) (Fig. 7D) .
BFA also blocked the cAMP-stimulated ATP release across the apical membrane of fresh bovine RPE cells. In these experiments, the cAMP cocktail increased the ATP levels 1.6-fold, to 64.7 Ϯ 12.9 nM (n ϭ 12) from control levels of 46.0 Ϯ 8.8 nM (n ϭ 12). A 30-min incubation with BFA produced a small but not significant reduction in ATP concentration to 52.4 Ϯ 9.7 nM (n ϭ 11) (Fig. 7E) .
Because vesicular release is known to require Ca 2ϩ (8) , the effect of the Ca 2ϩ chelator BAPTA on ATP release was examined. Incubation of ARPE-19 cells in cell-permeant BAPTA-AM for 30 min reduced the ATP release triggered by hypotonicity by Ͼ77% (Fig. 7F ). Levels were increased from 0.55 Ϯ 0.02 nM in control (n ϭ 16) to 5.63 Ϯ 0.82 nM in hypotonic conditions (n ϭ 14; 10.2-fold increase) but fell to only 1.68 Ϯ 0.29 nM in the presence of BAPTA and hypotonicity (n ϭ 16; 1.7-fold increase from control). This indicates that ATP release requires intracellular Ca 2ϩ and further supports a role for the vesicular process in the release of ATP from RPE cells.
DISCUSSION
In the present study, the potential involvement of CFTR and vesicular transport in the release of ATP from RPE cells was examined using fresh and cultured RPE cells. On the basis of the following observations, we conclude that CFTR can affect RPE physiology through its involvement in ATP release. Stimulating CFTR with a cAMP-activating cocktail led to ATP release from ARPE-19 cells and across the apical membrane of the fresh RPE eyecup. In these preparations, the hypotonically triggered release was prevented by both glibenclamide and the specific inhibitor CFTR-172. The elevation of intracellular . n ϭ 8 -16 . B: summary of the effects of the inhibitor BFA (10 g/ml) on the peak ATP release from ARPE-19 cells triggered with a 50% hypotonic solution. A 10-min preincubation with BFA was not enough to produce a significant block, while a 2-h preincubation with BFA did reduce the ATP levels surrounding ARPE-19 cells. *P Ͻ 0.001, significantly different from control. **P Ͻ 0.001, significantly different from hypotonic. C: 2-h preincubation with 10 g/ml BFA completely blocked the ATP release induced by the cAMP-activating mixture, while a 10-min incubation led to a small but insignificant reduction in ATP. *P Ͻ 0.001, significantly different from control. **P Ͻ 0.001, significantly different from hypotonic condition. D: when baseline levels of ATP were examined, a 2-h preincubation with 10 g/ml BFA was found to reduce basal ATP release to the bath, while a 10-min preincubation did not. *P Ͻ 0.002, significantly different from control. E: in the fresh bovine RPE eyecup, a 30-min preincubation with 10 g/ml BFA led to a small but insignificant reduction in the ATP release induced by the cAMP-stimulating cocktail. *P ϭ 0.02, significantly different from control. F: incubation with 20 M 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-AM for 30 min greatly reduced the release of ATP from ARPE-19 cells. *P Ͻ 0.001, significantly different from control. **P Ͻ 0.001, significantly different from hypotonic condition. Bars, means Ϯ SE.
Ca
2ϩ that followed a hypotonic challenge was prevented by the blocker CFTR-172. The transport inhibitor BFA and the Ca 2ϩ chelator BAPTA prevented ATP release, consistent with a role for vesicular transport in the process.
CFTR-172 was recently identified as a high-affinity inhibitor of CFTR that does not block volume-sensitive Cl Ϫ channels, Ca 2ϩ -sensitive Cl Ϫ channels, K ATP channels, AQP1, AE1, NHE3, or MDR-1 (28) . It produces a voltage-independent block and does not affect cAMP production, phosphatase activity, or single-channel conductance, but leads to a reduction in the mean closed time of the channel and may effect channel gating by binding to NBD-1 (28, 56) . Inhibition of anion transport by CFTR was maximal 10 min after application of CFTR-172, consistent with the enhanced inhibition of ATP release from RPE cells after preincubation. While the IC 50 for ATP release was slightly higher than that found for anion influx or measurements of short-circuit current (28, 56) , this is consistent with a more negative membrane potential in RPE cells. In addition, 10 M CFTR-172 produced maximal block both of ATP release in the present study and of anion flux from thyroid epithelial cells in previous work (28) . The effect of CFTR-172 on ATP release provides strong support for a role of CFTR in RPE physiology and is consistent with the idea that the Cl Ϫ and ATP efflux pathways share a common gating mechanism.
The block of ATP release with CFTR-172 also strengthens the link between ATP release and CFTR. CFTR has been associated with ATP efflux since Reisin et al. (45) indicated overexpression of CFTR led to increased ATP efflux. While additional conduits for ATP efflux are likely (11, 18, 47) and release from some cells can clearly occur in the absence of CFTR (18, 19, 37, 61) , the activity of CFTR is correlated with the augmentation of both baseline and stimulated ATP release in many cell types (33, 49) , and the presence of immunopurified CFTR in lipid bilayers is linked to ATP conductance (9) . ATP was initially thought to permeate the CFTR pore used by Cl Ϫ , but the precise pathway of ATP movement is now a matter of some debate. Selective elimination of Cl Ϫ and ATP conductance with different site mutations suggests that both CFTR and a separate cofactor are necessary for ATP efflux (23) . Anion channel blockers diphenylamine carboxylate and 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid were found to have differential effects on the Cl Ϫ and ATP conductance at the single-channel level, although the two pathways shared a gating mechanism (54) . The ability of CFTR-172 to prevent the release of ATP provides further evidence that one gating mechanism controls the passage of both anions (56) and identifies CFTR-172 as an important tool to explore the role of CFTR in release. However, the effects of CFTR-172 on Cl Ϫ and ATP currents must be examined at the single-channel level to provide further insight into the relationship between CFTR and ATP release.
Brefeldin A and CFTR-172 both blocked Ͼ70% of the hypotonically triggered release of ATP. This overlap implies that both processes apply to the same population of released ATP and act in series. Freshly synthesized CFTR has a half-life of 16 h (51), but CFTR on the cell surface can be internalized at 5%/min (27) . Because a 2-h preincubation with BFA completely inhibited the ATP release from our preparation, this process is unlikely to be dependent on synthesis of new protein but may instead involve recycled material. BFA has traditionally been associated with vesicular transport in the Golgi, but it can also interfere with a range of trafficking events, including transport of recycling endosomes to the plasma membrane. BFA prevented the formation of clathrin-coated buds at endosomes with Ͻ30-min incubation and reduced the clathrindependent endosomal recycling of transferrin within 10 min (53, 57) . The ability of cAMP to stimulate the insertion of CFTR-containing vesicles into the membrane has been hotly debated, with the process occurring in some cells but not in others (3, 38, 62) . At least part of the inhibition of ATP release by BFA in RPE cells indicated above is likely to be on the number of CFTR proteins already present in the membrane, because the block was time dependent and was observed in association with baseline levels of ATP released from unstimulated cells. Whether the larger increase in extracellular ATP levels after hypotonic stimulation reflects the insertion of CFTR-containing vesicles into the membrane as seen with other channel types (16, 58) awaits biochemical assessment of CFTR localization in stimulated and unstimulated cells. Regardless of the reason for this phenomenon, the ability of BFA to prevent ATP release by reducing the amount of CFTR reaching the membrane may reconcile opposing "channel" and "vesicular" theories about the release of ATP. Although the vesicular transport pathway has previously been implicated in the release of ATP from non-neuronal cells, the vesicles were assumed to contain transmitters (1, 5, 30, 58) . The hybrid mechanism illustrated in Fig. 8 may underlie ATP release from cells in which roles for both anion channels and vesicular transport have been identified.
The release of ATP into the interior of the bovine RPE eyecup is consistent with a functional localization of CFTR to the RPE apical membrane. In the absence of the retina, the eyecup interior represents subretinal space, and ATP sampled Fig. 8 . The hybrid mechanism in the ATP release from cultured human ARPE-19 and fresh bovine RPE cells. The hybrid hypothesis is a mixture of 2 alternative theories (hypotheses 1 and 2) to explain the mechanisms of ATP release from epithelial cells. In hypothesis 1, the ATP is released through a Cl Ϫ channel. The block of ATP release by 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB) supports this hypothesis, while the activation by cAMP and the inhibition observed with CFTR-172 and glibenclamide imply that the CFTR molecule is involved. However, the BFA and BAPTA experiments indicated that the vesicular pathway also contributed to ATP release from RPE cells. The hybrid hypothesis accommodates all of the data by proposing that the insertion of CFTR and/or Cl Ϫ channels into the membrane by vesicular fusion is necessary for ATP release. This insertion may represent a stimulated and/or constitutive process. Bars, means Ϯ SE.
from the eyecup interior is most likely to have moved from the RPE interior across the apical membrane into the space. CFTR has been immunolocalized to the apical and basolateral membranes of human RPE (4, 63) . While release from both membranes has been shown in airway epithelial cells (20) , the present study confirms only release across the apical membrane of fresh bovine RPE cells.
It is tempting to assume that the increase in subretinal ATP after the stimulation of apical CFTR would autostimulate P2Y 2 receptors and elevate Ca 2ϩ in vivo as shown in Fig. 6 . This rise in Ca 2ϩ may open basolateral Ca ϩ -sensitive Cl Ϫ channels and increase retinal to basolateral fluid absorption if the released ATP acts like the P2Y 2 agonists (29, 31) . The released ATP may also stimulate P2X receptors present on the RPE (46), but because their activation opens a cation channel, stimulation would further increase intracellular Ca 2ϩ . The effects of cAMP on the RPE are complex, possibly reflecting species differences or the action of CFTR on the apical and basolateral membranes in addition to other mechanisms (4, 22) . The activation of basolateral Cl Ϫ conductance after apical autostimulation with ATP would add an additional level of complexity that may underlie some of the variation in effects attributed directly to cAMP. However, the ability of CFTR-172 to alter Ca 2ϩ physiology shows a definitive role for the transporter, and in patients with cystic fibrosis, the fast oscillation of the electrooculogram was significantly reduced (33) , suggesting that CFTR function in wild types is regulated by light. It will be interesting to see whether subretinal ATP levels are also affected by light.
